Denosumab does not decrease the risk of lung metastases from bone giant cell tumour
Sign Up to like & getrecommendations! Published in 2018 at "International Orthopaedics"
DOI: 10.1007/s00264-018-4085-6
Abstract: PurposeThere are conflicting reports on the effect of denosumab on lung metastases in patients with giant cell tumor (GCT) of bone. To address these reports, we performed this study to determine if denosumab prevents lung… read more here.
Keywords: lung metastases; predictors lung; denosumab administration; lung ... See more keywords
Severe hypocalcemia and hypophosphatemia following Denosumab administration in a multi-comorbidity patient
Sign Up to like & getrecommendations! Published in 2024 at "Medicine and Pharmacy Reports"
DOI: 10.15386/mpr-2722
Abstract: The case is presented of an elderly patient (DCP) with extensive medical history, including osteoporosis, who developed hypocalcaemia and hypophosphataemia whilst treated with denosumab, while prescribed concomitant calcium and vitamin D therapies. The management of… read more here.
Keywords: severe hypocalcemia; denosumab administration; hypophosphatemia following; following denosumab ... See more keywords